AAAAAA
Results:
1-24
|
Results: 24
Authors:
OBRIEN SG
GOLDMAN JM
Citation: Sg. Obrien et Jm. Goldman, BUSULFAN ALONE AS CYTOREDUCTION BEFORE AUTOGRAFTING FOR CHRONIC MYELOGENOUS LEUKEMIA, Blood, 91(3), 1998, pp. 1091-1092
Authors:
OBRIEN SG
TOFSTED DH
Citation: Sg. Obrien et Dh. Tofsted, PHYSICS-BASED VISUALIZATION OF DENSE NATURAL CLOUDS - II - CLOUD-RENDERING ALGORITHM, Applied optics, 37(33), 1998, pp. 7680-7688
Authors:
TOFSTED DH
OBRIEN SG
Citation: Dh. Tofsted et Sg. Obrien, PHYSICS-BASED VISUALIZATION OF DENSE NATURAL CLOUDS - I - 3-DIMENSIONAL DISCRETE ORDINATES RADIATIVE-TRANSFER, Applied optics, 37(33), 1998, pp. 7718-7728
Authors:
OBRIEN SG
Citation: Sg. Obrien, AUTOGRAFTING FOR CHRONIC MYELOID-LEUKEMIA, Bailliere's clinical haematology, 10(2), 1997, pp. 369-388
Authors:
HAWKINS TE
MARLEY SB
OBRIEN SG
GORDON MY
GOLDMAN JM
Citation: Te. Hawkins et al., CD34(-LEUKEMIA - A COMPARISON OF LABORATORY GRADE COLUMNS() CELL SELECTION IN CHRONIC PHASE CHRONIC MYELOID), Bone marrow transplantation, 20(5), 1997, pp. 409-413
Authors:
RULE SAJ
SAVAGE DG
OBRIEN SG
ORCHARD K
MCDONALD C
DAVIDSON J
MATTHEY F
REILLY JT
BARDHAN G
MILLER E
CRANFIELD T
APPERLEY JF
GOLDMAN JM
Citation: Saj. Rule et al., INTERMEDIATE-DOSE BUSULFAN BEFORE AUTOGRAFTING FOR ADVANCED-PHASE CHRONIC MYELOID-LEUKEMIA, British Journal of Haematology, 94(4), 1996, pp. 694-698
Authors:
OBRIEN SG
SPENCER A
RULE S
HAWKINS T
SAVAGE D
APPERLEY JF
CHASE AJ
MCDONALD C
DAVIDSON RJ
GOLDMAN JM
Citation: Sg. Obrien et al., CHRONIC PHASE CML AUTOGRAFTING USING PBPCS MOBILIZED BY INTERMEDIATE-DOSE CHEMOTHERAPY AN UPDATE OF THE HAMMERSMITH EXPERIENC, British Journal of Haematology, 93, 1996, pp. 4-4
Authors:
OBRIEN SG
APPERLEY JF
SZYDLO R
SPENCER A
RULE SA
SAVAGE D
BLACKWELL J
ORCHARD K
CHASE A
HAWKINS TE
GOLDMAN JM
Citation: Sg. Obrien et al., HIGH-DOSE BUSULFAN ALONE AS CYTOREDUCTION BEFORE AUTOGRAFTING FOR CHRONIC MYELOID-LEUKEMIA - A FEASIBILITY STUDY, Blood, 88(10), 1996, pp. 3528-3528
Authors:
OBRIEN SG
GOLDMAN JM
Citation: Sg. Obrien et Jm. Goldman, THERAPEUTIC EXPLOITATION OF GENETIC-DEFECTS IN HEMATOLOGICAL MALIGNANCIES, Gene therapy, 2(7), 1995, pp. 435-436
Authors:
RULE SAJ
OBRIEN SG
SPENCER A
APPERLEY J
GOLDMAN JM
Citation: Saj. Rule et al., BONE-MARROW TRANSPLANTATION - REVIEW ARTICLES MUST ACCURATELY REFLECTCURRENT PRACTICE, BMJ. British medical journal, 310(6983), 1995, pp. 874-874
Authors:
OBRIEN SG
GOLDMAN JM
Citation: Sg. Obrien et Jm. Goldman, CURRENT APPROACHES TO HEMATOPOIETIC STEM-CELL PURGING IN CHRONIC MYELOID-LEUKEMIA, Journal of clinical oncology, 13(3), 1995, pp. 541-546
Authors:
OBRIEN SG
GEWIRTZ AM
RULE SA
HAWKINS TE
RATAJCZAK MZ
SAVAGE D
LUGER SM
GOLDMAN JM
Citation: Sg. Obrien et al., AUTOGRAFTING FOR CML USING BONE-MARROW PURGED WITH MYB ANTISENSE OLIGONUCLEOTIDE, Experimental hematology, 23(8), 1995, pp. 804-804
Authors:
OCALLAGHAN A
OBRIEN SG
NINKOVIC M
BUTCHER GP
FOSTER CS
WALTERS JRF
ROBERTS IAG
Citation: A. Ocallaghan et al., CHRONIC INTRAHEPATIC CHOLESTASIS IN SICKLE-CELL DISEASE REQUIRING EXCHANGE-TRANSFUSION, Gut, 37(1), 1995, pp. 144-147
Authors:
SPENCER A
OBRIEN SG
GOLDMAN JM
Citation: A. Spencer et al., OPTIONS FOR THERAPY IN CHRONIC MYELOID-LEUKEMIA, British Journal of Haematology, 91(1), 1995, pp. 2-7
Authors:
OBRIEN SG
CROSS NCP
KIRKLAND MA
GOLDMAN JM
Citation: Sg. Obrien et al., A NOVEL BCR-ABL CAT REPORTER CONSTRUCT SYSTEM CAN DEFINE THE FUNCTIONAL SPECIFICITY OF BCR-ABL ANTISENSE OLIGONUCLEOTIDES/, Blood, 86(10), 1995, pp. 2935-2935
Authors:
OBRIEN SG
KIRKLAND MA
GOLDMAN JM
Citation: Sg. Obrien et al., EUROPEAN SCHOOL OF ONCOLOGY TASK-FORCE PAPERS - GENE-THERAPY - A FUTURE IN CANCER MANAGEMENT - ANTISENSE THERAPY FOR MALIGNANT DISEASE, European journal of cancer, 30A(8), 1994, pp. 1160-1164
Authors:
RAMRAKHA PS
MARKS DI
OBRIEN SG
YACOUB M
SCHOFIELD JB
GOLDMAN JM
Citation: Ps. Ramrakha et al., ORTHOTOPIC CARDIAC TRANSPLANTATION FOR DILATED CARDIOMYOPATHY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Clinical transplantation, 8(1), 1994, pp. 23-26
Authors:
OBRIEN SG
KIRKLAND MA
MELO JV
RAO MH
DAVIDSON RJ
MCDONALD C
GOLDMAN JM
Citation: Sg. Obrien et al., ANTISENSE BCR-ABL OLIGOMERS CAUSE NONSPECIFIC INHIBITION OF CHRONIC MYELOID-LEUKEMIA CELL-LINES, Leukemia, 8(12), 1994, pp. 2156-2162
Authors:
OBRIEN SG
GOLDMAN JM
Citation: Sg. Obrien et Jm. Goldman, AUTOGRAFTING IN CHRONIC MYELOID-LEUKEMIA, Blood reviews, 8(2), 1994, pp. 63-69
Authors:
KIRKLAND MA
OBRIEN SG
GOLDMAN JM
Citation: Ma. Kirkland et al., ANTISENSE THERAPEUTICS IN HEMATOLOGICAL MALIGNANCIES, British Journal of Haematology, 87(3), 1994, pp. 447-452
Authors:
GOLDMAN JM
OBRIEN SG
Citation: Jm. Goldman et Sg. Obrien, RESIDUAL PH-NEGATIVE STEM-CELLS IN CHRONIC MYELOID-LEUKEMIA - SOMETIMES OR ALWAYS, Stem cells, 11, 1993, pp. 4-7
Authors:
KIRKLAND MA
OBRIEN SG
MCDONALD C
DAVIDSON RJ
CROSS NCP
GOLDMAN JM
Citation: Ma. Kirkland et al., BCR-ABL ANTISENSE PURGING IN CHRONIC MYELOID-LEUKEMIA, Lancet, 342(8871), 1993, pp. 614-614
Authors:
KIRKLAND MA
RAO H
OBRIEN SG
MCDONALD C
DAVIDSON RJ
GOLDMAN JM
Citation: Ma. Kirkland et al., NON-SEQUENCE SPECIFIC EFFECTS OF BCR-ABL ANTISENSE OLIGOMERS ON CML CELL-LINES, Blood, 82(10), 1993, pp. 10000040-10000040
Authors:
OBRIEN SG
KIRKLAND MA
DAVIDSON RJ
MCDONALD C
GOLDMAN JM
Citation: Sg. Obrien et al., ANTISENSE OLIGODEOXYNUCLEOTIDES FOR IN-VITRO PURGING OF AUTOLOGOUS BONE-MARROW IN CHRONIC PHASE CHRONIC MYELOID-LEUKEMIA, Blood, 82(10), 1993, pp. 10000119-10000119
Risultati:
1-24
|